Company: FLDDW
Filing Date: 2025-07-11
Form Type: S-1
Source: 0001213900-25-062935
Chunk: 112

Company: Fold Holdings, Inc.
Filing Date: 2025-07-11
Form: S-1
Chunk 112
---
 be subject to limitations agreed upon by the contracting parties. Cohen & Company Securities, LLC (“Cohen”) acted as the placement agent in connection with the transactions contemplated by the Facility, for which the Company has agreed to issue 75,000shares of Common Stock to Cohen at the time of the placement of the Facility in connection with the placement of the Facility (such shares, the “Placement Shares”), and to pay customary placement fees and reimburse certain expenses of Cohen. The Company cannot effect any sales under the Facility and SZOP will not have any obligation to purchase Advance Shares under the Facility to the extent that after giving effect to such purchase and sale the aggregate number of Advance Shares issued under the Facility together with any shares of Common Stock issued in connection with any other transaction that may be considered part of the same series of transactions, where the number of shares issued 59 would exceed the number of shares representing 19.99% of the issued and outstanding shares of Common Stock as of the date of the Facility (the “Exchange Cap”), unless the Company has obtained stockholder approval as required for issuance of Common Stock in excess of the Exchange Cap, in accordance with the applicable rules of Nasdaq. Accordingly, the Company may not have access to the right to sell the full Commitment to SZOP. As of June 15, 2025, there were 46,434,655shares of Common Stock outstanding, and therefore the Exchange Cap is 9,282,287shares of Common Stock. In connection with the Facility, the Company is registering for resale up to 9,282,287shares of Common Stock under this prospectus, which represents the maximum number of shares of Common Stock that it could register without obtaining stockholder approval. There are substantial risks to the Company’s stockholders as a result of the sale and issuance of Shares to SZOP under the Facility. These risks include the potential for substantial dilution and significant declines in the share price of the Company’s securities. See “ Risk Factors — Risks Related to this Offering” elsewhere in this prospectus. Conditions to Each Advance under the Facility SZOP’s obligation to accept Advance Notices that are delivered by the Company in accordance with the terms of the Facility and to purchase Advance Shares under the Facility is subject to the satisfaction, at the applicable Advance Notice Date, of certain conditions, including without limitation: (i) the accuracy in all material respects of the representations and warranties of the Company included in the Facility; (ii) the registration statement pursuant to which SZOP is permitted to utilize